SITC 29th Annual Meeting: Concurrent Session - Tumor Microenvironment and ImmunosuppressionNovember 7-9, 2014Gaylord National Hotel & Convention Center National Harbor, MDSession Co-Chairs Suzanne Ostrand-Rosenberg, PhD – University of Maryland Baltimore County Weiping Zou, MD, PhD – University of Michigan SITC 29th Annual Meeting Organizers Arthur A. Hurwitz, PhD - National Cancer Institute Kim A. Margolin, MD - Stanford University Daniel E. Speiser, MD - Ludwig Center for Cancer Research of the University of Lausanne Walter J. Urba, MD, PhD - Earle A. Chiles Research InstituteProgram SummaryThe tumor microenvironment is often an immune suppressed locale that impedes the efficacy of cancer immunotherapies as well as interfering with naturally arising anti-tumor immunity. A variety of mechanisms contribute to this immune suppression, including regulatory cells of both lymphoid and myeloid origin. Induction of these suppressive networks is frequently mediated by tumor-produced factors which perturb the differentiation of immune cells and polarize them towards a tumor-promoting phenotype. This session at the 29th Annual Meeting on November 7, 2014 in National Harbor, MD focused on several of the immune suppressive mechanisms that are common in many cancer patients and will discuss some of the strategies that are being developed to inhibit tumor-induced immune suppression and restore immune competence. About the SITC 29th Annual MeetingThe SITC 29th Annual Meeting provided a multidisciplinary educational and interactive environment focused on improving outcomes for current and future patients with cancer by incorporating strategies based on basic and applied cancer immunotherapy. The meeting consisted of cutting-edge research presentations by experts in the field, oral and poster abstract presentations, and ample opportunities for structured and informal discussions, including important networking opportunities. In addition, the meeting included updates on major national and international initiatives coming from academia, government and industry, as well as important society projects. #ClinicalTrials #ColonCancer #Lymphoma #Melanoma #OvarianCancer #Video #AnnualMeeting#SITC #TherapeuticAntibodies #Clinician #Industry #Oncologist #Researcher #2014 #PresentationSlides
Meeting: SITC 29th Annual Meeting; Session: Concurrent Session — Tumor Microenvironment and Immunosuppression; Presentation: Integrating Immunoregulatory and Vascular Signaling Programs Through Lectin-Glycan Interactions; Presenter: Gabriel A. Rabinovich, PhD – Instituto de Biología y Medicina Experimental (IBYME); Date: November 7, 201400:31:57
Meeting: SITC 29th Annual Meeting; Session: Concurrent Session — Tumor Microenvironment and Immunosuppression; Presentation: Immune Impact on Cancer Stemness; Presenter: Weiping Zou, MD, PhD – University of Michigan; Date: November 7, 201400:18:20